• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴露评估和监测抗肿瘤药物在医疗环境中的准备:系统评价。

Exposure Assessment and Monitoring of Antiblastic Drugs Preparation in Health Care Settings: A Systematic Review.

机构信息

Department of Medical and Surgical Sciences, University of Bologna, Via Pelagio Palagi 9, 40138 Bologna (Ita-ly).

Department of Science and High Technology, University of Insubria, via Valleggio 11, 22100 Como (Italy).

出版信息

Med Lav. 2024 Apr 24;115(2):e2024012. doi: 10.23749/mdl.v115i2.15609.

DOI:10.23749/mdl.v115i2.15609
PMID:38686575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11181217/
Abstract

Several antiblastic drugs (ADs) are classified as carcinogenic, mutagenic, and/or toxic for reproduction. Despite established guidelines and safe handling technologies, ADs contamination of the work environments could occur in healthcare settings, leading to potential exposure of healthcare staff. This systematic review aims to investigate the main techniques and practices for assessing ADs occupational exposure in healthcare settings. The reviewed studies unveil that workplace contamination by ADs appears to be a still-topical problem in healthcare settings. These issues are linked to difficulties in guaranteeing: (i) the adherence to standardized protocols when dealing with ADs, (ii) the effective use of personal protective equipment by operators involved in the administration or management of ADs, (iii) a comprehensive training of the healthcare personnel, and (iv) a thorough health surveillance of exposed workers. A "multi-parametric" approach emerges as a desirable strategy for exposure assessment. In parallel, exposure assessment should coincide with the introduction of novel technologies aimed at minimizing exposure (i.e., risk management). Assessment must consider various departments and health operators susceptible to ADs contamination, with a focus extended beyond worst-case scenarios, also considering activities like surface cleaning and logistical tasks related to ADs management. A comprehensive approach in ADs risk assessment enables the evaluation of distinct substance behaviors and subsequent exposure routes, affording a more holistic understanding of potential risks.

摘要

一些抗肿瘤药物(ADs)被归类为致癌、致突变和/或对生殖有毒。尽管有既定的指导方针和安全处理技术,但 ADs 在医疗保健环境中的污染仍有可能发生,导致医护人员潜在暴露。本系统评价旨在研究评估医疗保健环境中 ADs 职业暴露的主要技术和实践。综述研究表明,ADs 对工作场所的污染似乎仍然是医疗保健环境中的一个重要问题。这些问题与以下方面的困难有关:(i)在处理 ADs 时遵守标准化方案,(ii)操作人员有效使用个人防护设备进行 ADs 的管理或管理,(iii)对医护人员进行全面培训,以及(iv)对暴露工人进行全面的健康监测。“多参数”方法似乎是暴露评估的一种理想策略。同时,暴露评估应与引入旨在最小化暴露的新技术(即风险管理)同时进行。评估必须考虑到易受 ADs 污染的各个部门和卫生工作者,不仅要考虑最坏情况下的情况,还要考虑表面清洁和与 ADs 管理相关的后勤任务等活动。对 ADs 风险的综合评估方法能够评估不同物质的行为和随后的暴露途径,从而更全面地了解潜在风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c7/11181217/66c47d03097c/MDL-115-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c7/11181217/66c47d03097c/MDL-115-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c7/11181217/66c47d03097c/MDL-115-12-g001.jpg

相似文献

1
Exposure Assessment and Monitoring of Antiblastic Drugs Preparation in Health Care Settings: A Systematic Review.暴露评估和监测抗肿瘤药物在医疗环境中的准备:系统评价。
Med Lav. 2024 Apr 24;115(2):e2024012. doi: 10.23749/mdl.v115i2.15609.
2
Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data.职业环境中抗肿瘤药物的暴露:生物监测数据的系统评价。
Int J Environ Res Public Health. 2022 Mar 21;19(6):3737. doi: 10.3390/ijerph19063737.
3
Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC.有关在进行 HIPEC/PIPAC 的化疗药物配置单元和手术室中,护理人员接触抗肿瘤药物风险的安全处理知识和实践。
J Oncol Pharm Pract. 2023 Oct;29(7):1628-1636. doi: 10.1177/10781552221144303. Epub 2022 Dec 13.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Predictors of adherence to safe handling practices for antineoplastic drugs: A survey of hospital nurses.抗肿瘤药物安全操作规范依从性的预测因素:一项针对医院护士的调查
J Occup Environ Hyg. 2016;13(3):203-12. doi: 10.1080/15459624.2015.1091963.
6
Impact of lack of knowledge on risk perception and protective practices of home nurses handling antineoplastic drugs.缺乏知识对家庭护士处理抗肿瘤药物的风险认知和防护措施的影响。
J Oncol Pharm Pract. 2024 Mar;30(2):313-321. doi: 10.1177/10781552231174181. Epub 2023 May 7.
7
A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments.一种评估医院环境中抗肿瘤药物职业暴露的新方法。
Arh Hig Rada Toksikol. 2018 Sep 1;69(3):226-237. doi: 10.2478/aiht-2018-69-3125.
8
Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units.低风险和高风险操作人员处理伊立替康对肿瘤日间护理单元医护人员血液污染的影响。
J Oncol Pharm Pract. 2023 Jun;29(4):905-911. doi: 10.1177/10781552221090965. Epub 2022 Apr 5.
9
Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.医护人员遵守呼吸道传染病感染预防与控制(IPC)指南的障碍与促进因素:一项快速定性证据综合分析
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD013582. doi: 10.1002/14651858.CD013582.
10
Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs).监测三十种抗肿瘤药物的表面污染情况:表面暴露水平(SELs)的新提议。
Med Pr. 2022 Dec 6;73(5):383-396. doi: 10.13075/mp.5893.01288. Epub 2022 Nov 14.

本文引用的文献

1
Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC.术中热灌注化疗(HIPEC)和腹腔热灌注化疗(PIPAC)期间外科工作人员处理抗肿瘤药物的认知、知识和防护措施。
Pleura Peritoneum. 2022 Apr 13;7(2):77-86. doi: 10.1515/pp-2021-0151. eCollection 2022 Jun 1.
2
Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.环境监测在评估法国综合癌症中心两个站点中接触环磷酰胺的职业暴露风险控制中的应用。
Ann Work Expo Health. 2022 Nov 15;66(9):1215-1223. doi: 10.1093/annweh/wxac035.
3
Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data.
职业环境中抗肿瘤药物的暴露:生物监测数据的系统评价。
Int J Environ Res Public Health. 2022 Mar 21;19(6):3737. doi: 10.3390/ijerph19063737.
4
Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.奥沙利铂腹腔热灌注化疗后医护人员职业暴露与环境污染评估
Toxicol Appl Pharmacol. 2021 Oct 15;429:115694. doi: 10.1016/j.taap.2021.115694. Epub 2021 Aug 21.
5
Perception of risk of exposure in the management of hazardous drugs in home hospitalization and hospital units.家庭住院和医院病房中管理有害药物时的暴露风险感知。
PLoS One. 2021 Jul 1;16(7):e0253909. doi: 10.1371/journal.pone.0253909. eCollection 2021.
6
Knowledge and Practices on the Safe Handling of Cytotoxic Drugs Among Oncology Nurses Working at Tertiary Teaching Hospitals in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴三级教学医院肿瘤科护士对细胞毒性药物安全处理的知识与实践
Drug Healthc Patient Saf. 2021 Mar 29;13:71-80. doi: 10.2147/DHPS.S289025. eCollection 2021.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Evaluation of a safe infusion device on reducing occupational exposure of nurses to antineoplastic drugs: a comparative prospective study. Contamoins-1.一种安全输液装置降低护士接触抗肿瘤药物职业暴露的评估:一项对照前瞻性研究。Contamoins-1。
Int Arch Occup Environ Health. 2021 Aug;94(6):1317-1325. doi: 10.1007/s00420-021-01679-x. Epub 2021 Mar 17.
9
Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contamination.评估输注后管冲洗在降低细胞毒性污染风险方面的效果。
Am J Health Syst Pharm. 2020 Oct 30;77(22):1866-1873. doi: 10.1093/ajhp/zxaa357.
10
External contamination of antineoplastic drug vials: an occupational risk to consider.抗肿瘤药物小瓶的外源性污染:一个需要考虑的职业风险。
Eur J Hosp Pharm. 2022 Sep;29(5):284-286. doi: 10.1136/ejhpharm-2020-002440. Epub 2020 Sep 25.